225 related articles for article (PubMed ID: 23145984)
1. Vocal fold insufficiency: medialization laryngoplasty vs calcium hydroxylapatite microspheres (Radiesse Voice®).
Cantillo-Baños E; Jurado-Ramos A; Gutiérrez-Jódas J; Ariza-Vargas L
Acta Otolaryngol; 2013 Mar; 133(3):270-5. PubMed ID: 23145984
[TBL] [Abstract][Full Text] [Related]
2. Comparison of voice outcome after vocal fold augmentation with fat or calcium hydroxylapatite.
Lodder WL; Dikkers FG
Laryngoscope; 2015 May; 125(5):1161-5. PubMed ID: 25545723
[TBL] [Abstract][Full Text] [Related]
3. Effect of temporary vocal fold injection medialization on the rate of permanent medialization laryngoplasty in unilateral vocal fold paralysis patients.
Yung KC; Likhterov I; Courey MS
Laryngoscope; 2011 Oct; 121(10):2191-4. PubMed ID: 21898421
[TBL] [Abstract][Full Text] [Related]
4. Posterior glottic gap and age as factors predicting voice outcome of injection laryngoplasty in patients with unilateral vocal fold paralysis.
Choi J; Son YI; So YK; Byun H; Lee EK; Yun YS
J Laryngol Otol; 2012 Mar; 126(3):260-6. PubMed ID: 22017979
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis on the efficiency of the injection laryngoplasty technique using calcium hydroxyapatite (CaHA): the thyrohyoid approach versus the cricothyroid approach.
Woo SH; Son YI; Lee SH; Park JJ; Kim JP
J Voice; 2013 Mar; 27(2):236-41. PubMed ID: 23280385
[TBL] [Abstract][Full Text] [Related]
6. Vocal fold augmentation with injectable calcium hydroxylapatite: short-term results.
Rosen CA; Thekdi AA
J Voice; 2004 Sep; 18(3):387-91. PubMed ID: 15331112
[TBL] [Abstract][Full Text] [Related]
7. Injection versus medialization laryngoplasty for the treatment of unilateral vocal fold paralysis: follow-up at six months.
Vinson KN; Zraick RI; Ragland FJ
Laryngoscope; 2010 Sep; 120(9):1802-7. PubMed ID: 20641088
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of different treatment modalities for glottic insufficiency.
Dursun G; Boynukalin S; Ozgursoy OB; Coruh I
Am J Otolaryngol; 2008; 29(1):7-12. PubMed ID: 18061825
[TBL] [Abstract][Full Text] [Related]
9. A Novel Endoscopic Arytenoid Medialization for Unilateral Vocal Fold Paralysis.
Rovó L; Ambrus A; Tóbiás Z; Wootten CT; Bach Á
Laryngoscope; 2021 Mar; 131(3):E903-E910. PubMed ID: 32790084
[TBL] [Abstract][Full Text] [Related]
10. Injection laryngoplasty outcomes in irradiated and nonirradiated unilateral vocal fold paralysis.
Chang J; Courey MS; Al-Jurf SA; Schneider SL; Yung KC
Laryngoscope; 2014 Aug; 124(8):1895-9. PubMed ID: 24473831
[TBL] [Abstract][Full Text] [Related]
11. Arytenoid adduction with nerve-muscle pedicle transfer vs arytenoid adduction with and without type I thyroplasty in paralytic dysphonia.
Hassan MM; Yumoto E; Sanuki T; Kumai Y; Kodama N; Baraka MA; Wahba H; Hafez NG; El-Adawy AA
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):833-9. PubMed ID: 25123168
[TBL] [Abstract][Full Text] [Related]
12. Long-term voice handicap index after type II thyroplasty using titanium bridges for adductor spasmodic dysphonia.
Sanuki T; Yumoto E; Kodama N; Minoda R; Kumai Y
Auris Nasus Larynx; 2014 Jun; 41(3):285-9. PubMed ID: 24369905
[TBL] [Abstract][Full Text] [Related]
13. Medialization thyroplasty in glottis insufficiency due to unilateral vocal fold paralysis and after laser cordectomies - preliminary report.
Rzepakowska A; Osuch-Wójcikiewicz E; Sielska-Badurek E; Niemczyk K
Otolaryngol Pol; 2017 Feb; 71(1):22-29. PubMed ID: 28485294
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of voice outcome comparing calcium hydroxylapatite injection laryngoplasty to silicone thyroplasty.
Shen T; Damrose EJ; Morzaria S
Otolaryngol Head Neck Surg; 2013 Feb; 148(2):197-208. PubMed ID: 23077153
[TBL] [Abstract][Full Text] [Related]
15. Revision Transcervical Medialization Laryngoplasty for Unilateral Vocal Fold Paralysis.
Parker NP; Barbu AM; Hillman RE; Zeitels SM; Burns JA
Otolaryngol Head Neck Surg; 2015 Oct; 153(4):593-8. PubMed ID: 25968059
[TBL] [Abstract][Full Text] [Related]
16. [Quality of voice and life after injectionlaryngoplasty using VOX Implants(®) (polydimethylsiloxane)].
Koelmel JC; Sittel C
Laryngorhinootologie; 2014 May; 93(5):316-20. PubMed ID: 24519317
[TBL] [Abstract][Full Text] [Related]
17. Revision laryngeal surgery for the suboptimal injection of calcium hydroxylapatite.
Chheda NN; Rosen CA; Belafsky PC; Simpson CB; Postma GN
Laryngoscope; 2008 Dec; 118(12):2260-3. PubMed ID: 19029857
[TBL] [Abstract][Full Text] [Related]
18. Injection laryngoplasty outcomes in vocal fold paralysis using calcium hydroxylapatite.
Koçdor P; Tulunay-Uğur ÖE
Kulak Burun Bogaz Ihtis Derg; 2014; 24(5):271-5. PubMed ID: 25513870
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 24-month voice outcomes after injection laryngoplasty with calcium hydroxylapatite or hyaluronic acid in patients with unilateral vocal fold paralysis.
Miaśkiewicz B; Panasiewicz A; Nikiel K; Włodarczyk E; Gos E; Szkiełkowska A
Am J Otolaryngol; 2022; 43(1):103207. PubMed ID: 34537510
[TBL] [Abstract][Full Text] [Related]
20. Additional Injection Laryngoplasty for Patients With Unilateral Vocal Fold Paralysis.
Choi N; Won S; Jin H; Kim HJ; Park W; Son YI
Laryngoscope; 2020 Dec; 130(12):2863-2868. PubMed ID: 32057117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
